Wikipedia

14-3-3 protein

(Redirected from 14-3-3 proteins)

14-3-3 proteins are a family of conserved regulatory molecules that are expressed in all eukaryotic cells. 14-3-3 proteins have the ability to bind a multitude of functionally diverse signaling proteins, including kinases, phosphatases, and transmembrane receptors. More than 200 signaling proteins have been reported as 14-3-3 ligands.

14-3-3
Cartoon diagram of Human 14-3-3 protein beta PDB entry 2bq0 [1]
Identifiers
Symbol14-3-3
PfamPF00244
InterProIPR000308
SMART14_3_3
PROSITEPDOC00633
SCOP21a4o / SCOPe / SUPFAM
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Elevated amounts of 14-3-3 protein in cerebrospinal fluid are usually a sign of rapid neurodegeneration; a common indicator of Creutzfeldt–Jakob disease.[2]

Molecular structure of a 14-3-3 protein dimer bound to a peptide.

Properties

edit

Seven genes encode seven distinct 14-3-3 proteins in most mammals (See Human genes below) and 13-15 genes in many higher plants, though typically in fungi they are present only in pairs. Protists have at least one. Eukaryotes can tolerate the loss of a single 14-3-3 gene if multiple genes are expressed, but deletion of all 14-3-3s (as experimentally determined in yeast) results in death.[citation needed]

14-3-3 proteins are structurally similar to the Tetratrico Peptide Repeat (TPR) superfamily, which generally have 9 or 10 alpha helices, and usually form homo- and/or hetero-dimer interactions along their amino-termini helices. These proteins contain a number of known common modification domains, including regions for divalent cation interaction, phosphorylation & acetylation, and proteolytic cleavage, among others established and predicted.[3]

14-3-3 binds to peptides. There are common recognition motifs for 14-3-3 proteins that contain a phosphorylated serine or threonine residue, although binding to non-phosphorylated ligands has also been reported. This interaction occurs along a so-called binding groove or cleft that is amphipathic in nature. To date, the crystal structures of six classes of these proteins have been resolved and deposited in the public domain.[citation needed]

14-3-3 recognition motifs[4]
Canonical 
R[^DE]{0,2}[^DEPG]([ST])(([FWYLMV].)
                        |([^PRIKGN]P)
                        |([^PRIKGN].{2,4}[VILMFWYP]))
C-terminal 
R[^DE]{0,2}[^DEPG]([ST])[^P]{0,1}$
Non-phos (ATP) 
IR[^P][^P]N[^P][^P]WR[^P]W[YFH][ITML][^P]Y[IVL]
All entrys are in regular expression format. Newlines are added in "or" cases for readability. Phosphorylation sites are in bold.

The motif sites are way more diverse than the patterns here suggest. For an example with a modern recognizer using an artificial neural network, see the cited article.[5]

Discovery and naming

edit

14-3-3 proteins were initially found in brain tissue in 1967 and purified using chromatography and gel electrophoresis. In bovine brain samples, 14-3-3 proteins were located in the 14th fraction eluting from a DEAE-cellulose column and in position 3.3 on a starch electrophoresis gel.[6]

Function

edit

14-3-3 proteins play an isoform-specific role in class switch recombination. They are believed to interact with the protein Activation-Induced (Cytidine) Deaminase in mediating class switch recombination.[7]

Phosphorylation of Cdc25C by CDS1 and CHEK1 creates a binding site for the 14-3-3 family of phosphoserine binding proteins. Binding of 14-3-3 has little effect on Cdc25C activity, and it is believed that 14-3-3 regulates Cdc25C by sequestering it to the cytoplasm, thereby preventing the interactions with CycB-Cdk1 that are localized to the nucleus at the G2/M transition.[8]

The eta (YWHAH) isoform is reported to be a biomarker (in synovial fluid) for rheumatoid arthritis.[9] In a systematic review, 14-3-3η has been described as a welcome addition to the rheumatology field. The authors indicate that the serum based 14-3-3η marker is additive to the armamentarium of existing tools available to clinicians, and that there is adequate clinical evidence to support its clinical benefits in the management of patients diagnosed with rheumatoid arthritis (RA). [10]

14-3-3 proteins bind to and sequester the transcriptional coregulators YAP/TAZ to the cytoplasm, inhibiting their function.

14-3-3 regulating cell-signalling

edit

Human genes

edit

The 14-3-3 proteins alpha and delta (YWHAA and YWHAD) are phosphorylated forms of YWHAB and YWHAZ, respectively.

In plants

edit

The presence of large gene families of 14-3-3 proteins in the Viridiplantae kingdom reflects their essential role in plant physiology. A phylogenetic analysis of 27 plant species clustered the 14-3-3 proteins into four groups.

14-3-3 proteins activate the auto-inhibited plasma membrane P-type H+ ATPases. They bind the ATPases' C-terminus at a conserved threonine.[12]

References

edit
  1. ^ Yang, X.; Lee, W. H.; Sobott, F.; Papagrigoriou, E.; Robinson, C. V.; Grossmann, J. G.; Sundstrom, M.; Doyle, D. A.; Elkins, J. M. (2006). "Structural basis for protein-protein interactions in the 14-3-3 protein family". Proc. Natl. Acad. Sci. U.S.A. 103 (46): 17237–17242. Bibcode:2006PNAS..10317237Y. doi:10.1073/pnas.0605779103. PMC 1859916. PMID 17085597.
  2. ^ Takahashi H, Iwata T, Kitagawa Y, Takahashi RH, Sato Y, Wakabayashi H, Takashima M, Kido H, Nagashima K, Kenney K, Gibbs CJ, Kurata T (November 1999). "Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease". Clinical and Diagnostic Laboratory Immunology. 6 (6): 983–5. doi:10.1128/CDLI.6.6.983-985.1999. PMC 95810. PMID 10548598.
  3. ^ Bridges D, Moorhead GB (August 2005). "14-3-3 proteins: a number of functions for a numbered protein". Science's STKE. 2005 (296): re10. doi:10.1126/stke.2962005re10. PMID 16091624. S2CID 5795342.
  4. ^ "ELM search: "14-3-3"". Eukaryotic Linear Motif resource. Retrieved 16 May 2019.
  5. ^ Madeira F, Tinti M, Murugesan G, Berrett E, Stafford M, Toth R, Cole C, MacKintosh C, Barton GJ (July 2015). "14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides". Bioinformatics. 31 (14): 2276–83. doi:10.1093/bioinformatics/btv133. PMC 4495292. PMID 25735772.
  6. ^ Aitken, A (2006). "14-3-3 proteins: a historic overview". Semin Cancer Biol. 50 (6): 993–1010. doi:10.1023/A:1021261931561. PMID 16678438. S2CID 41949194.
  7. ^ Xu Z, Zan H, Pone EJ, Mai T, Casali P (June 2012). "Immunoglobulin class-switch DNA recombination: induction, targeting and beyond". Nat Rev Immunol. 12 (7): 517–31. doi:10.1038/nri3216. PMC 3545482. PMID 22728528.
  8. ^ Cann KL, Hicks GG (December 2007). "Regulation of the cellular DNA double-strand break response". Biochemistry and Cell Biology. 85 (6): 663–74. doi:10.1139/O07-135. PMID 18059525.
  9. ^ Kilani, R. T.; Maksymowych, W. P.; Aitken, A.; Boire, G.; St-Pierre, Y.; Li, Y.; Ghahary, A. (2007). "Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation". The Journal of Rheumatology. 34 (8): 1650–1657. PMID 17611984.
  10. ^ Abdelhafiz D, Kilborn S, Bukhari M (June 2021). "The role of 14-3-3 η as a biomarker in rheumatoid arthritis". Rheumatology and Immunology Research. 2 (2): 87–90. doi:10.2478/rir-2021-0012. PMC 9524784. PMID 36465971. S2CID 238231522.
  11. ^ Saha M, Carriere A, Cheerathodi M, Zhang X, Lavoie G, Rush J, Roux PP, Ballif BA (October 2012). "RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation". The Biochemical Journal. 447 (1): 159–66. doi:10.1042/BJ20120938. PMC 4198020. PMID 22827337.
  12. ^ Jahn TP, Schulz A, Taipalensuu J, Palmgren MG (February 2002). "Post-translational modification of plant plasma membrane H(+)-ATPase as a requirement for functional complementation of a yeast transport mutant". The Journal of Biological Chemistry. 277 (8): 6353–8. doi:10.1074/jbc.M109637200. PMID 11744700.

Further reading

edit
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=14-3-3_protein&oldid=1242538137"